Artificial intelligence in diabetic retinopathy screening: from idea to a medical device in clinical practice
Authors:
Jozefína Vaľková; Matěj Adam; Jan Hlaváček
Authors place of work:
Aireen a. s., Praha
Published in the journal:
Čas. Lék. čes. 2023; 162: 290-293
Category:
Original Article
Summary
With the growing significance of artificial intelligence in healthcare, new perspectives are emerging in primary care. Diabetic retinopathy, a microvascular complication of diabetes mellitus, often remains unnoticed until patient is facing complications. Artificial intelligence presents a promising solution that can enhance the accessibility of diabetic retinopathy screening for a broader range of patients. The key challenge lies in successfully integrating the solution into clinical practice, a demanding process with multiple phases to ensure the resulting medical device is effective and safe for patient use.
Aireen software uses artificial intelligence to perform diabetic retinopathy screening on retinal images captured by optical fundus cameras. The medical device complies with European Medical Device Regulation 2017/745 and was introduced to the market in 2023. Collaboration between physicians and the development team played a crucial role throughout the entire lifecycle of the medical device. Physicians were engaged in defining the intended use of the medical device, risk analysis, data annotation for training and software validation, as well as throughout a clinical trial. A clinical trial was conducted on 1,274 patients with type 1 and type 2 diabetes mellitus, where Aireen medical device achieved a sensitivity of 94.0% and a specificity of 90.7% compared to the reference evaluation. This clinical trial confirmed the potential of Aireen to enhance the availability of diabetic retinopathy screening and early disease detection.
Keywords:
diabetic retinopathy, screening, artificial intelligence
Zdroje
- . 40 % diabetiků chybí oční vyšetření, nově ho mohou poskytnout přímo diabetologové. VZP ČR, 2022. Dostupné na: www.vzp.cz/o-nas/aktuality/40-diabetiku-chybi-ocni-vysetreni-nove-ho-mohou-poskytnout-primo-diabetologove
- Karen I, Svačina š. Diabetes mellitus. Novelizace 2020. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. SVL ČLS JEP, Praha, 2020.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Artificial intelligence in medicine and healthcare: Opportunity and/or threat
- Zogala D. Artificial intelligence in medical imaging
- Trends in fertility and abortion in Czechia
- Questions and questionnaires about acute climacteric syndrome